Navigation Links
Cyprotex Purchases Applied Biosystems Sciex QTRAP(R) 5500 LC-MS/MS
Date:11/19/2008

MACCLESFIELD, England, November 19 /PRNewswire-FirstCall/ -- Cyprotex are proud to announce the introduction in their facilities of one of the most sensitive ion trap and triple quadrupole instruments in the industry.

The QTRAP(R) 5500 LC-MS/MS offers unparalleled sensitivity and impressive speed by uniting the world's most sensitive triple quadrupole with the world's most sensitive and fastest scanning linear ion trap. It combines exceptional quantitative and qualitative analytical potential with no sacrifice in performance for either capability, and allows accurate and precise ion detection over a wide dynamic range.

The introduction of the QTRAP(R) 5500 is part of Cyprotex's expansion of our bioanalytical facility and will enable us to offer a comprehensive bioanalytical method development and validation service as well as an enhanced and highly sensitive metabolite profiling and identification service. The instrument will increase the likelihood of detecting poorly sensitive molecules which are problematic in conventional LC-MS/MS systems.

Dr Anthony Baxter, Cyprotex's Chief Executive Officer, comments on the purchase of the new QTRAP(R) 5500 LC-MS/MS, "Cyprotex will be able to deliver a superior bioanalytical service which will set us apart from many of our competitors. This state of the art technology allows highly sensitive and accurate analysis giving us the very best chance of successfully detecting and quantifying our customers' molecules."

Ian Clarke, Applied Biosystems' Country Commercial Leader UK & Ireland, comments, "The QTRAP(R) 5500 LC-MS/MS has only recently been launched and Cyprotex are the first company in the UK to benefit from this next generation technology. This addition to their facility will greatly enhance Cyprotex's bioanalytical service enabling their customers to access the most sensitive ion trap LC-MS/MS instruments in the industry."

   http://www.cyprotex.com

    For further information:
    Cyprotex PLC
    Helen Gill PhD, Product Development Manager
    Tel: +44-1625-505-100
    h.gill@cyprotex.com



'/>"/>
SOURCE Cyprotex Discovery Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cyprotex Introduces New Product Line Cloe(R) Select - a Portfolio of Bespoke ADME and PK Services
2. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
3. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
4. George Washington University Hospital Purchases Orthocrats TraumaCad(TM) for Orthopedic Preoperative Planning
5. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
6. CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million
7. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
8. Enigma Diagnostics Announces Patent Licence With Applied Biosystems
9. Nanoscale carbon materials research wins the 2008 Julius Springer Prize for Applied Physics
10. Applied Computational Technologies Appoints a New CEO
11. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Origin (Origin Agritech, LLC, a subsidiary of Origin Agritech Ltd.) (NASDAQ: ... Arcadia (Arcadia Biosciences, Inc., NASDAQ: RKDA), a ... and nutritional products, today announced their collaboration to achieve the first-ever ... China to the United States ... ...
(Date:2/22/2017)... ... February 22, 2017 , ... NDA Partners Chairman Carl ... Deputy Director in the FDA CDRH Division of Cardiovascular, Respiratory, and Neurological Devices ... as an Expert Consultant. , In Dr. Spyker’s accomplished career, he held positions ...
(Date:2/22/2017)... and SAN DIEGO , ... (the "Company") (OTCQB:CELZ) announced today expansion of its ... stem cell product through establishment of laboratory facilities ... activities at the San Diego BioLabs facility, a ... Ingelheim, Novartis, and Sanofi. In November ...
(Date:2/21/2017)... 2017 Synthetic Biologics, Inc. (NYSE MKT: SYN), ... to protect and restore the health of patients, intends to report ... 2016 on Thursday, March 2, 2017, and to host a conference ... for the call is as follows: U.S. (toll free): ... ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 ... Senate Judiciary Committee, Janice Kephart of Identity ... President Donald Trump,s "Executive Order: Protecting the ... (Jan. 27, 2017):  "As President Trump,s ,Travel ... Circuit has now essentially banned the travel ban, it ...
(Date:2/9/2017)... The biomass boiler market report by Transparency Market Research ... in terms of revenue (US$ Mn) based on the ... boilers has been segmented on the basis of feedstock ... based on feedstock type, has been segmented into woody ... urban residues, and others. On the basis of product ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
Breaking Biology News(10 mins):